New initiatives boost awareness and fundraising: Kicks to Beat Cancer, Craig Sager Style Day, Blizzard/Overwatch League Season Preview and WeRateDogs “H*ck Cancer” campaign.
ESPN’s 12th annual V Week for Cancer Research set a new record, helping raise more than $8.3 million for the V Foundation for Cancer Research. That represents an 83% year-over-year increase.
“The 2018 V Week was ESPN’s most successful year yet. We are honored to share stories of determination and perseverance from sports fans such as Purdue alumni, Tyler Trent who helped raise much needed funds for innovative cancer research,” said Kevin Martinez, vice president of ESPN Corporate Citizenship. “We’re so appreciative of the continued support from the teams, leagues, corporate sponsors and ESPN fans who rally around the cause.”
“V Week provides extraordinary visibility to the V Foundation and our quest to end cancer,” said Susan Braun, CEO of the V Foundation for Cancer Research. “And critically, ESPN is tireless in helping us raise funds for research to make that happen. Our deepest thanks goes to every single person at ESPN, every fan, and every sponsor. Together, we can beat cancer!”
This year ESPN engaged new partners and created innovative fundraising and awareness-building campaigns, which ran from Nov. 27 — Dec. 8, which educated fans on the importance of cancer research including:
Additionally, this fall, ESPN created the Tyler Trent Fund at the V Foundation for Cancer Research to support cancer research for Adolescents and Young Adults. Tyler Trent, a Purdue University student who was battling osteosarcoma, a particularly rare and aggressive form of bone cancer, captured the hearts of America when his story was featured across many ESPN shows. He fought great obstacles through his perseverance and determination, and was inspired by Jim Valvano’s rally cry, “Don’t Give Up.”. Tyler, who lost his battle this month, wished to make the biggest impact in the fight against cancer so that other young cancer patients and their families do not have to go through the agony his family went through. ESPN will continue to raise money for the Tyler Trent Fund.
Over the past 12 years, V Week fundraising has totaled over $30 million for cancer research.
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC
Published: December 20th 2024 | Updated: December 20th 2024The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.